These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 9519509)

  • 41. The inhalers of the future? A review of dry powder devices on the market today.
    Smith IJ; Parry-Billings M
    Pulm Pharmacol Ther; 2003; 16(2):79-95. PubMed ID: 12670777
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Review of therapeutically equivalent alternatives to short acting beta(2) adrenoceptor agonists delivered via chlorofluorocarbon-containing inhalers.
    Hughes DA; Woodcock A; Walley T
    Thorax; 1999 Dec; 54(12):1087-92. PubMed ID: 10567628
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aerosol devices and asthma therapy.
    Berger W
    Curr Drug Deliv; 2009 Jan; 6(1):38-49. PubMed ID: 19418954
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reformulation of Stmerin(®) D CFC formulation using HFA propellants.
    Murata S; Izumi T; Ito H
    Pharm Dev Technol; 2013; 18(6):1314-8. PubMed ID: 22519407
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Medical aerosol propellant interference with infrared anaesthetic gas monitors.
    Levin PD; Levin D; Avidan A
    Br J Anaesth; 2004 Jun; 92(6):865-9. PubMed ID: 15121726
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The rejuvenated pressurised metered dose inhaler.
    Bell J; Newman S
    Expert Opin Drug Deliv; 2007 May; 4(3):215-34. PubMed ID: 17489650
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The ozone layer and metered dose inhalers.
    Boulet LP
    Can Respir J; 1998; 5(3):176-9. PubMed ID: 9707462
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human safety and pharmacokinetics of the CFC alternative propellants HFC 134a (1,1,1,2-tetrafluoroethane) and HFC 227 (1,1,1,2,3,3, 3-heptafluoropropane) following whole-body exposure.
    Emmen HH; Hoogendijk EM; Klöpping-Ketelaars WA; Muijser H; Duistermaat E; Ravensberg JC; Alexander DJ; Borkhataria D; Rusch GM; Schmit B
    Regul Toxicol Pharmacol; 2000 Aug; 32(1):22-35. PubMed ID: 11029265
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-CFC metered dose inhalers: the patent landscape.
    Bowman PA; Greenleaf D
    Int J Pharm; 1999 Sep; 186(1):91-4. PubMed ID: 10469927
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reverse water-in-fluorocarbon emulsions for use in pressurized metered-dose inhalers containing hydrofluoroalkane propellants.
    Butz N; Porté C; Courrier H; Krafft MP; Vandamme TF
    Int J Pharm; 2002 May; 238(1-2):257-69. PubMed ID: 11996829
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The transition in practice: health professionals and patients.
    Partridge MR
    Br J Clin Pract Suppl; 1997 May; 89():32-6. PubMed ID: 9519511
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alcohol-based pressurised metered-dose inhalers for use in asthma: a descriptive study.
    Alrasbi M; Sheikh A
    Prim Care Respir J; 2008 Jun; 17(2):111-3. PubMed ID: 18338091
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Re: inhaled beclomethassone (BDP) with non-CFC propellent (HFA 134a) is equivalent to BDP-CFC for the treatment of asthma (Respir Med 19999; 93:245-251).
    Zanen P
    Respir Med; 2000 Feb; 94(2):180-1. PubMed ID: 10714429
    [No Abstract]   [Full Text] [Related]  

  • 54. Innovations and perspectives of metered dose inhalers in pulmonary drug delivery.
    Keller M
    Int J Pharm; 1999 Sep; 186(1):81-90. PubMed ID: 10469926
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modulation of aerosol clouds produced by pressurised inhalation aerosols.
    Brambilla G; Ganderton D; Garzia R; Lewis D; Meakin B; Ventura P
    Int J Pharm; 1999 Sep; 186(1):53-61. PubMed ID: 10469923
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CFC replacements: safety testing, approval for use in metered dose inhalers.
    Graepel P; Alexander DJ
    J Aerosol Med; 1991; 4(3):193-200. PubMed ID: 10147679
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Moisture transport into chlorofluorocarbon-free metered dose inhalers.
    Williams G
    J Allergy Clin Immunol; 1999 Dec; 104(6):S227-9. PubMed ID: 10588979
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Problems raised by the reformulation of inhalations after the removing of propulsors "chlorofluorocarbons" (CFC)].
    Aiache JM
    Ann Pharm Fr; 1997; 55(2):62-8. PubMed ID: 9181702
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The transition in practice: policy makers and purchasers.
    Bevan B
    Br J Clin Pract Suppl; 1997 May; 89():28-31. PubMed ID: 9519510
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recent development of drug delivery systems for the treatment of asthma and related disorders.
    Takizawa H
    Recent Pat Inflamm Allergy Drug Discov; 2009 Nov; 3(3):232-9. PubMed ID: 19663776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.